Bionano Genomics, Inc.
BNGOFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
31
Cost of Revenue
30
Gross Profit
0
Gross Margin
1.2%
Operating Income
-104
Operating Margin
-337.9%
Net Income
-112
Net Margin
-364.0%
EPS (Basic)
$-88.13
EPS (Diluted)
$-88.13
EBITDA
-97
EBITDA Margin
-316.7%
2023
12/31/2023
Revenue
36
Cost of Revenue
27
Gross Profit
10
Gross Margin
26.5%
Operating Income
-215
Operating Margin
-596.0%
Net Income
-232
Net Margin
-643.7%
EPS (Basic)
$-24508.80
EPS (Diluted)
$-24516.00
EBITDA
-214
EBITDA Margin
-591.4%
2022
12/31/2022
Revenue
28
Cost of Revenue
22
Gross Profit
6
Gross Margin
21.4%
Operating Income
-132
Operating Margin
-473.7%
Net Income
-133
Net Margin
-476.9%
EPS (Basic)
$-16505.40
EPS (Diluted)
$-16505.40
EBITDA
-120
EBITDA Margin
-432.8%
2021
12/31/2021
Revenue
18
Cost of Revenue
14
Gross Profit
4
Gross Margin
21.5%
Operating Income
-77
Operating Margin
-428.8%
Net Income
-72
Net Margin
-402.8%
EPS (Basic)
$-9421.20
EPS (Diluted)
$-9421.20
EBITDA
-74
EBITDA Margin
-410.7%
2020
12/31/2020
Revenue
9
Cost of Revenue
6
Gross Profit
3
Gross Margin
32.6%
Operating Income
-39
Operating Margin
-453.4%
Net Income
-41
Net Margin
-483.4%
EPS (Basic)
$-14194.80
EPS (Diluted)
$-14194.80
EBITDA
-36
EBITDA Margin
-418.3%